Jeffrey Vrieland
Family Medicine · Lawrenceville, GANPI 1235477340
Payments from drug & device makers
Across 301 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$692
- Amgen$683
- Lilly USA, LLC$443
- Amarin Pharma, Inc.$364
- AbbVie$359
- plus $2K from 34 others
What the payments were for
- Food & beverage$5,754100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 49 | $1,177 |
| Novo Nordisk | 52 | $692 |
| Amgen | 29 | $683 |
| Lilly USA, LLC | 25 | $443 |
| Amarin Pharma, Inc. | 17 | $364 |
| AbbVie(2 entities) | 17 | $359 |
| Abbott | 15 | $312 |
| GSK | 14 | $237 |
| Boehringer Ingelheim | 9 | $176 |
| Exact Sciences | 7 | $130 |
| Optinose US, Inc. | 6 | $121 |
| Eisai Inc. | 8 | $114 |
| Sanofi-aventis U.S. LLC | 6 | $111 |
| Astellas Pharma US Inc | 6 | $108 |
| Genentech USA, Inc. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Orexo US, Inc. | 2 | $46 |
| Endo Pharmaceuticals Inc. | 3 | $44 |
| Antares Pharma, Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Indivior Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Mylan Specialty L.p. | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Bayer | 1 | $26 |
| Merck | 2 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Alk-abello, Inc | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Dermira, Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Linus Health, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,760 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 49 | $76,968 |
| FarxigaDapagliflozin Propanediol | 62 | $74,896 |
| OzempicSemaglutide | 61 | $59,713 |
| JanuviaSitagliptin Phosphate | 41 | $40,160 |
| MounjaroTirzepatide | 29 | $32,007 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $26,320 |
| EliquisApixaban | 27 | $19,433 |
| EntrestoSacubitril/Valsartan | 12 | $10,087 |
| Modafinil | 14 | $8,469 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $7,556 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $7,555 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $7,529 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $5,893 |
| Atorvastatin Calcium | 560 | $4,102 |
| DayvigoLemborexant | 12 | $3,927 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $176 | $76,96849 claims |
| AstraZenecaFarxiga | $1,177 | $74,89662 claims |
| Novo NordiskOzempic | $692 | $59,71361 claims |
| MerckJanuvia | $25 | $40,16041 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $237 | $33,84934 claims |
| Lilly USA, LLCMounjaro | $443 | $32,00729 claims |
| NovartisEntresto | $17 | $10,08712 claims |
| Eisai Inc.Dayvigo | $114 | $3,92712 claims |
| AbbVieSynthroid | $359 | $3,40831 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Lawrenceville
- Lloydstone JacobsLawrenceville$146K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.